The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV Hiroaki AkamatsuKiichiro NinomiyaNobuyuki Yamamoto Special Article Open access 02 May 2019 Pages: 731 - 770
Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells Naohide OueKazuhiro SentaniWataru Yasui Invited Review Article 12 April 2019 Pages: 771 - 778
Dawn of precision medicine on gastric cancer Takahiro IshiiAkihito KawazoeKohei Shitara Invited Review Article 11 April 2019 Pages: 779 - 788
Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer Susumu OkanoTomohiro EnokidaMakoto Tahara Original Article 22 February 2019 Pages: 789 - 797
A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width Yakup BozkayaBediz KurtFatih GĂĽrler Original Article 19 February 2019 Pages: 798 - 806
Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients Rurina WatanukiTetsu HayashidaYuko Kitagawa Original Article 27 February 2019 Pages: 807 - 814
Discrimination between breast invasive ductal carcinomas and benign lesions by optimizing quantitative parameters derived from dynamic contrast-enhanced MRI using a semi-automatic method Jiawen YangJiandong Yin Original Article 27 February 2019 Pages: 815 - 824
Inflammation–nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma Xiao-Chun NiJie XuShuang-Jian Qiu Original Article 24 April 2019 Pages: 825 - 835
Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety Hiroaki TaniokaMichitaka HondaHideyuki Mishima Original Article 18 February 2019 Pages: 836 - 841
Comparative assessment of prognostic outcomes between first-generation antiandrogens and novel androgen-receptor-axis-targeted agents in patients with non-metastatic castration-resistant prostate cancer Hideaki MiyakeYuto MatsushitaAtsushi Otsuka Original Article 09 February 2019 Pages: 842 - 847
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective study Taro IguchiSatoshi TamadaTatsuya Nakatani Original Article 11 February 2019 Pages: 848 - 856
Oncologic and reproductive outcomes of cystectomy as a fertility-sparing treatment for early-stage epithelial ovarian cancer Hiroaki KajiyamaShiro SuzukiFumitaka Kikkawa Original Article 15 February 2019 Pages: 857 - 862
Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma Yoko YamamotoRyu KanzakiMeinoshin Okumura Original Article 26 February 2019 Pages: 863 - 870
Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale Daisuke FuruyaMikako MoriaiSatoshi Takahashi Original Article 23 February 2019 Pages: 871 - 875
Use of direct oral anti-coagulants for the treatment of venous thromboembolism in patients with advanced cancer: a prospective observational study Takuya OyakawaNao MuraokaKeita Mori Original Article 12 February 2019 Pages: 876 - 881